Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Xtant Medical Holdings ( (XTNT) ).
On December 1, 2025, Xtant Medical Holdings and its subsidiary Surgalign SPV completed the divestiture of certain assets related to its Coflex and CoFix spinal products to Companion Spine for $17.5 million, part of which was paid via an $8.2 million unsecured promissory note initially maturing on January 15, 2026, and simultaneously sold its foreign hardware business subsidiary, Paradigm Spine GmbH, to Companion Spine SAS for $1.7 million, both deals subject to purchase price adjustments that could reduce the note’s principal. On January 15, 2026, Xtant and Companion Spine amended the promissory note to extend its maturity to January 31, 2026 and modified the Paradigm Spine purchase agreement to shift payment of an estimated $1,742,000 positive purchase price adjustment to January 31, 2026, clarifying timing of cash inflows and potentially affecting the company’s near-term liquidity profile following these portfolio-divesting transactions.
The most recent analyst rating on (XTNT) stock is a Buy with a $0.78 price target. To see the full list of analyst forecasts on Xtant Medical Holdings stock, see the XTNT Stock Forecast page.
Spark’s Take on XTNT Stock
According to Spark, TipRanks’ AI Analyst, XTNT is a Neutral.
Xtant Medical Holdings shows a positive outlook with strong revenue growth and operational improvements, as highlighted in the earnings call. Technical indicators support a bullish trend. However, high valuation metrics and ongoing profitability challenges temper the overall score.
To see Spark’s full report on XTNT stock, click here.
More about Xtant Medical Holdings
Xtant Medical Holdings is a medical device company focused on spinal surgery solutions, including implantable products such as its Coflex and CoFix systems, and has operated both in the United States and internationally through subsidiaries like Paradigm Spine GmbH for its hardware business outside the U.S.
Average Trading Volume: 270,011
Technical Sentiment Signal: Sell
Current Market Cap: $95.76M
For a thorough assessment of XTNT stock, go to TipRanks’ Stock Analysis page.